First Time Loading...

Sonoma Pharmaceuticals Inc
NASDAQ:SNOA

Watchlist Manager
Sonoma Pharmaceuticals Inc Logo
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Watchlist
Price: 0.1601 USD 0.69% Market Closed
Updated: Apr 30, 2024

Sonoma Pharmaceuticals Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sonoma Pharmaceuticals Inc
Pre-Tax Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Pre-Tax Income
-$5.1m
CAGR 3-Years
-21%
CAGR 5-Years
17%
CAGR 10-Years
2%
Johnson & Johnson
NYSE:JNJ
Pre-Tax Income
$22.2B
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Pre-Tax Income
$8.4B
CAGR 3-Years
N/A
CAGR 5-Years
7%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Pre-Tax Income
$1.1B
CAGR 3-Years
-48%
CAGR 5-Years
-22%
CAGR 10-Years
-24%
Merck & Co Inc
NYSE:MRK
Pre-Tax Income
$1.9B
CAGR 3-Years
-31%
CAGR 5-Years
-26%
CAGR 10-Years
-10%
Eli Lilly and Co
NYSE:LLY
Pre-Tax Income
$6.6B
CAGR 3-Years
-3%
CAGR 5-Years
12%
CAGR 10-Years
1%

See Also

What is Sonoma Pharmaceuticals Inc's Pre-Tax Income?
Pre-Tax Income
-5.1m USD

Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Pre-Tax Income amounts to -5.1m USD.

What is Sonoma Pharmaceuticals Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
2%

Over the last year, the Pre-Tax Income growth was 27%. The average annual Pre-Tax Income growth rates for Sonoma Pharmaceuticals Inc have been -21% over the past three years , 17% over the past five years , and 2% over the past ten years .